65 /100
HIGH RISK
Score updated May 30, 2026

CVKD — Cadrenal Therapeutics, Inc. Dilution Risk Tracker

Track CVKD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CVKD — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
85
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
35%
📉 Score Deterioration 50%
• Score rose 43 points recently (worsening)
• Score in HIGH risk zone (65/100)
💰 Capital Raise 35%
• Low cash runway: 4 months remaining
🔔 Track CVKD — Get forecast alerts →

💹 Market Data

Market Cap$15.27M
Shares Outstanding3.08M
Float2.38M
Cash$2.31M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 0.5% shares (2025Q4 vs prior)
18 institutional holders · 121.5K shares
#1 VANGUARD GROUP INC 53.9K shares
#2 DRW Securities, LLC 25.2K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 14.5K shares
+ 15 more holders Sign up free to view →

📉 Short Interest

Short Interest70.9K
Days to Cover1.0
% of Float3.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Sep 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2023
EFFECT EFFECT Apr 29, 2026
424B3 ATM Apr 29, 2026
S-3 SHELF Apr 21, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CVKD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CVKD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CVKD
📊 CVKD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CVKD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.